Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Dermatologic 1

Conditions

Osteosarcoma 1Melanoma 1Lymphoma 1Endocrine Gland Neoplasms 1

Interventions

X-Rays 6Phantoms, Imaging 6Specimen Handling 5Magnetic Resonance Spectroscopy 5Nuclear Medicine Department, Hospital 4Biopsy 3ulixertinib 2tipifarnib 2tazemetostat 2tanespimycin 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2glucarpidase 2ensartinib 2Vemurafenib 2Triptorelin Pamoate 2Psychiatric Rehabilitation 2Leucovorin 2LY3023414 2Electroacupuncture 2Drug Therapy 2Carboplatin 2trimetrexate glucuronate 1surufatinib 1ixabepilone 1gamma-Glutamyl Hydrolase 1etoposide phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Osteosarcoma × Psilocybin × Lymphoid × Clear all
NCT06416085 2026-03-05

Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer

University Health Network, Toronto

Phase 2 Active not recruiting
15 enrolled
DermatologicLymphoidSarcoma

Endocrine Gland Neoplasms, Lymphoma, Melanoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡